KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$228000.0.

  • Vir Biotechnology's Other Non Operating Income rose 7446.81% to -$228000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$580000.0, marking a year-over-year increase of 8187.5%. This contributed to the annual value of -$2.2 million for FY2024, which is 7529.75% up from last year.
  • As of Q3 2025, Vir Biotechnology's Other Non Operating Income stood at -$228000.0, which was up 7446.81% from $226000.0 recorded in Q2 2025.
  • Vir Biotechnology's 5-year Other Non Operating Income high stood at $27.0 million for Q3 2022, and its period low was -$26.2 million during Q4 2022.
  • Its 5-year average for Other Non Operating Income is -$866473.7, with a median of -$228000.0 in 2025.
  • The largest annual percentage gain for Vir Biotechnology's Other Non Operating Income in the last 5 years was 4212812.5% (2022), contrasted with its biggest fall of 37400000.0% (2022).
  • Over the past 5 years, Vir Biotechnology's Other Non Operating Income (Quarter) stood at -$7000.0 in 2021, then tumbled by 374000.0% to -$26.2 million in 2022, then surged by 94.33% to -$1.5 million in 2023, then surged by 65.93% to -$506000.0 in 2024, then surged by 54.94% to -$228000.0 in 2025.
  • Its Other Non Operating Income stands at -$228000.0 for Q3 2025, versus $226000.0 for Q2 2025 and -$72000.0 for Q1 2025.